Skip to content

Main Navigation

  • About us
    • History
    • Mission, vision & values
    • Leadership
    • Scientific advisors
    • Our team
    • Social impact (CSR)
  • Science & Services
    • Contexts of use
      • Trial design and analyses
      • Program strategies and efficiencies
      • Special/specific populations
      • Special considerations
      • Regulatory interactions
    • Pharmetheus Platforms
      • Model-Informed Drug Development
      • PBPK & PBBM
      • Pharmacometrics
      • QSP
    • Solutions
      • Milestone Analysis
      • Embedded Scientist
      • Expert Advice
      • Training workshop
      • Scientific Publication
    • Specific services
      • Model-Informed Bioequivalence & Biosimilarity
      • Accelerated submission
      • Concentration-QTc (C-QTc) modeling
      • Data-driven strategies for pediatric success
    • Publications
    • Case studies
  • Careers
    • Working with us
    • Open positions
    • Employee stories
  • Events
  • News
  • Contact us
  • LinkedIn

Population Pharmacokinetic Simulations of Two Paliperidone Palmitate Formulations

PAGE 24 (2015) Abstr 3643.
Magnusson MO, Samtani MN, Plan EL, Jonsson EN, Rossenu S, Vermeulen A.
CNSConferencePharmacometricsProgram strategies and efficiencies

Pharmetheus Affiliates

Portrait-of-Mats-Magnusson_Pharmetheus
Chief Operations Officer

Mats Magnusson

See bio
Portrait-of-Elodie-Plan_Pharmetheus-1
Chief Business Development Officer & Deputy CEO

Elodie Plan

See bio
Portrait-of-Niclas-Jonsson-Pharmetheus
Scientific Director & Pharmacometrics Scientific Lead

Niclas Jonsson

See bio

Contact

Pharmetheus AB
Kungsängstull 4
753 19 Uppsala, Sweden

Visiting address: Dragarbrunnsgatan 77, 5th floor

Contact us

Links

  • Home
  • Newsletter
  • LinkedIn
  • Whistleblower
  • Privacy Policy
  • Cookie Policy
  • Consent Preferences

Services

  • Contexts of use
  • Pharmetheus platforms
  • Solutions
  • Case studies
  • Publications

About

Pharmetheus is a consultancy firm helping clients reduce uncertainty in technical and regulatory processes, increasing confidence in the development of new medicines that can improve patients’ lives.